Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print

Financial Report: WuXi PharmaTech



Published August 11, 2011
Related Searches: R&D Manufacturing Manufacturing
WuXi PharmaTech 2Q11

2Q Revenues: $101.1 million  (+25%)

2Q Earnings: $18.7 million (+36%)

YTD Revenues: $194.7 million (+20%)

YTD Earnings: $36.9 million (+26%)

Comments: Growth in the quarter was driven by Manufacturing Services revenue, up 149% to $21.0 million and China-based Laboratory Services, up 15% to $60.3 million. Laboratory Services were up 10% to $80.1 million in the quarter.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On